English
Français
Deutsch
العربية
Português
Español
简體(tǐ)中文(wén)

News
Home / News / Company News
  • Goldsite on TrendOn February 18th, Goldsite Diagnostics Inc., was invited to attend the 2024 Guangdong High-quality Development Conferences as the key representative from #enterprises, along with leading #hightech companies, to name a few, #BYD, #Tencent, #Mindray, and #DJI.About Guangdong High-qual
  • Düsseldorf, Germany- Today marks the grand opening of the 2023 MEDICA exhibition in Düsseldorf, Germany, drawing the global medical industry's attention. After months of meticulous preparation, the Goldsite team debuts with several inno
  • (Bangkok, Thailand, 18 August, 2023) The Medlab Asia 2023 has drawn its curtains, leaving behind a trail of innovation, collaboration, and impactful connections. As we pause to reflect on this event, we are thrilled to share our journey and the significant impact it has made on our presence in the

  • Goldsite Showcased at AACC 2023

    2023-07-27
    As we close this chapter, we want to express our gratitude towards the organizers of the 2023 AACC as well as to all those who visited our booth, engaged in insightful discussions, and showed interest in our products. We can't wait to see what the next year brings, and we look forward to connecting

  • Goldsite Office Relocation Announcement

    2023-03-31
    Expanding to the new headquarter building, the new location will provide the necessary infrastructure for Goldsite Diagnostics Inc. to continue to build on our current momentum and sales in the China and International markets.
  • Dear valued client,We would like to thank you for your support and trust throughout the past year. We look forward to continuing our partnership and achieving great success together.We would like to inform you that our office will be closed for the Chinese New Year holiday from January 20th to Janua

  • GOLDSITE All Products Now Registered on UK MHRA

    2022-08-26
    Glad to share with you the news that all Goldsite's products are registered in the United Kingdom Medicines&Healthcare products Regulatory Agency (MHRA) now.#goldsite #mhra #unitedkingdom #uk #healthcare #ivd #ivdr #clinical #lab #laboratories #clinics #hospital #health
  • Omicron subvariants BA.4 and BA.5 now are responsible for the surge of cases globally. New studies suggest that BA.4 and BA.5 are so far the most transmissible variants. World Health Organization experts has recognized BA.4 and BA.5 continue to drive waves of cases, hospitalisation

  • 澳門藥物(wù)監督管理(lǐ)局批准進口GOLDSITE新(xīn)冠病毒快速抗原測試試劑

    2022-06-20
    澳門藥物(wù)監督管理(lǐ)局官方網站主頁近期更新(xīn)獲准進口的新(xīn)冠病毒快速抗原檢測試劑製造商(shāng)名單，國賽生物(wù)(Goldsite Diagnostics Inc) 作為65家獲批的生產商(shāng)之一，生產的SARS-COV-2 ANTIGEN KIT (COLLOIDAL GOLD)(FOR SELF TESTING) （新(xīn)型冠狀病毒檢測試劑盒 自測用(yòng)）名列其中，此試劑盒用(yòng)於在12分(fēn)鐘內快速檢測新(xīn)冠病毒感染，可(kě)快速有(yǒu)效地用(yòng)於社區大規模人群篩查，相比於核酸PCR檢測，成本低，反應快，更省去排隊做核酸的時間，自己在家即可(kě)操作，無需專業人士操作，不需要具備複雜的醫學訓練，即使是兒童和老人，也可(kě)以自行採樣，既方便又(yòu)可(kě)以避免大規
  • Aotearoa New Zealand Ministry of Health approved on Goldsite SARS-CoV-2 Antigen Kit (Colloidal Gold) for self-testing, allowing Goldsite make the list of one of the 18 manufacturers get approved for legal market in NZ, by 10 June, 2022.This kit is designed to detect new coronavirus infections within
Goldsite Diagnostics Inc., founded in 1999, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents.

Get in touch

    (+86)-755-26890807

        (+86)-755-26897973
   export@goldsite.com.cn

 

Copyright © 1999- 2023 Goldsite Diagnostics Inc., All rights reserved.